Cargando…
When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
The dualistic classification of epithelial ovarian cancer (EOC) into “type I” and “type II” is widely applied in the research setting; it is used as a convenient way of conceptualizing different mechanisms of tumorigenesis. However, this classification conflicts with recent molecular insights of the...
Autores principales: | Salazar, Carolina, Campbell, Ian G., Gorringe, Kylie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309131/ https://www.ncbi.nlm.nih.gov/pubmed/30627526 http://dx.doi.org/10.3389/fonc.2018.00654 |
Ejemplares similares
-
Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017) -
The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
por: Khabele, Dineo
Publicado: (2014) -
A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008) -
RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers
por: Abraham, Hannah G., et al.
Publicado: (2021) -
Dynamic modular architecture of protein-protein interaction networks beyond the dichotomy of ‘date' and ‘party' hubs
por: Chang, Xiao, et al.
Publicado: (2013)